LIMN – liminatus pharma, inc. - class a (US:NASDAQ)
Stock Stats
News
Liminatus Pharma (NASDAQ:LIMN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Liminatus Pharma (NASDAQ:LIMN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Liminatus Pharma (NASDAQ:LIMN) was downgraded by analysts at Wall Street
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation [Yahoo! Finance]
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
Form 8-K Liminatus Pharma, Inc. For: Nov 19
Form 10-Q Liminatus Pharma, Inc. For: Sep 30
Form 10-Q Liminatus Pharma, Inc. For: Jun 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.